Who we are

The Royal Marsden opened its doors in 1851 as the world’s first hospital dedicated to cancer diagnosis, treatment, research and education.

Today it operates as a specialist cancer hospital and National Institute for Health and Care Research (NIHR) Biomedical Research Centre for Cancer, working closely with its principal academic partner, the Institute of Cancer Research (ICR). 

Together, The Royal Marsden and the ICR are ranked in the top five cancer centres in the world for the impact of their research, treating over 59,000 NHS and private patients every year. 

It is a centre of excellence with an international reputation for groundbreaking research and pioneering the very latest in cancer treatments and technologies, as well as specialising in cancer diagnosis and education

The Royal Marsden operates from two centres, in Chelsea and Sutton, and we also have a Medical Daycare Unit at Kingston Hospital.  We are the founder and host of RM Partners, the Cancer Alliance for west London, which includes St George’s Healthcare NHS Foundation Trust, Imperial. Healthcare NHS Trust, and other trust and clinical commissioning group (CCG) partners across north west and south west London.

We are currently exploring proposals to sensitively add to the Chelsea site, respecting the rich heritage and history of our buildings, so that we can secure the hospital’s future in the borough for the long-term.

Our vision is to expand surgical capacity and help more patients access our world-leading care. You can learn more about the proposal at our consultation hub.

HRH The Prince of Wales became President of The Royal Marsden in 2007, following a long royal connection with the hospital.